New podcast on how drug safety can help fight resistant bugs

Research / 04 July 2022

Jean Marie Vianney Habarugira and Albert Figueras are all for using pharmacovigilance databases for AMR surveillance. Hear them out on the latest episode of Drug Safety Matters.


Managing antimicrobial resistance (AMR) will require innovative solutions from many different disciplines. Could pharmacovigilance be one of them?

In the latest episode of Drug Safety Matters, Jean Marie Vianney Habarugira and Albert Figueras, who have been investigating how drug safety tools could help track AMR, tell podcast host Federica Santoro why they think it’s time the two communities joined forces for good.

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Related Articles

UMC science gets personal

Expanding sources of evidence for better signal detection – New podcast out now

Unmasking data in the COVID-19 vaccine era

You may also like

UMC science gets personal

The Research corner film series puts UMC pharmacovigilance scientists in the spotlight as they discuss their research and its implications for pharmacovigilance science.

Research / 16 March 2023

Unmasking data in the COVID-19 vaccine era

First came the COVID-19 pandemic. Then came the COVID-19 vaccines. Then came millions of COVID-19 vaccine reports of suspected side effects. What are the implications of that?

Research / 25 November 2022

Expanding sources of evidence for better signal detection – New podcast out now

In this digital age, can pharmacovigilance experts leverage on new types of data to find evidence for signals? Listen to the latest Drug Safety Matters podcast to find out.

Research / 23 February 2023

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more